The Aprotinin Story: Lessons in Drug Regulation and Safety
نویسندگان
چکیده
Issues of drug regulation and safety are a familiar concern within the pharmaceutical industry and often do not emerge until several years after a drug has been on the market. The antifibrinolytic drug aprotinin (Trasylol) was developed by Bayer Pharmaceuticals and approved to prevent excessive bleeding in patients undergoing coronary artery bypass grafting surgery. After several years of widespread use of the drug in cardiac procedures, two observational studies demonstrated a risk of aprotinin for serious complications such as renal failure and myocardial infarction. These observations led to a prolonged review of the drug’s safety label by the Food and Drug Administration and to the revelation that Bayer had withheld the results of a privately commissioned observational study which demonstrated these reported complications. This essay highlights the ethical issues raised by the aprotinin saga and discusses the importance of transparency, honesty, and clinical equipoise in drug regulation and safety.
منابع مشابه
Impact of aprotinin and renal function on mortality: a retrospective single center analysis
BACKGROUND An estimated up to 7% of high-risk cardiac surgery patients return to the operating room for bleeding. Aprotinin was used extensively as an antifibrinolytic agent in cardiac surgery patients for over 15 years and it showed efficacy in reducing bleeding. Aprotinin was removed from the market by the U.S. Food and Drug Administration after a large prospective, randomized clinical trial ...
متن کاملTelevision Programs and Development of Moral Values
In this study, the relationship between the viewing of television programs (programs toward God, the lessons of the Quran, the Fath) in the fields of Tehran citizens to moral values (Faith, virtue, purification and self-purification, prayer, reading culture, integrity, justice-oriented, good relations with others) have been investigated. The statistical population of this research over 15 years...
متن کاملAPROTININ: EFFECTS ON BLOOD LOSS AND FRESH FROZEN PLASMA REQUIREMENT IN CARDIAC OPERATIONS
ABSTRACT Background: Aprotinin has been used increasingly to reduce postoperative blood loss in open-heart operations due to the potentialities for complications and high cost, it would seem reasonable to use aprotinin more selectively in small doses in the prime solution of the pump. Methods: We prospectively studied the effect of preoperative low dose aprotinin [2 million units (230mg)] on b...
متن کاملFactors Affecting Medication Errors from Nurses' Perspective: Lessons Learned
Introduction: Medical errors are among the most threatening faults against patient’s safety in all countries. The most frequent medical errors are medication errors which can lead to serious effects and even death in patients. Therefore, this study aimed to explain factors affecting medication eroors from the viewpoints of nurses in order to present strategies to reduce these errors. Methods:...
متن کاملFrom the Bench to the Clinic: Story and Lessons from VRX496, the First Lentivector Ever Tested in a Phase I Clinical Trial
Gene therapy for HIV-1 infection has been proposed as an alternative to antiretroviral drug regimens due to emerging drug resistance and toxicity that raises concerns about HAART as a long-term therapy. VIRxSYS has developed an HIV-based lentiviral vector platform for delivery of genetic therapies. For the first clinical application of the gene delivery technology, VIRxSYS created VRX496, a len...
متن کامل